| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |